# MetSense Pilot and Feasibility

> **NCT07264062** · NA · ENROLLING_BY_INVITATION · sponsor: **Kaiser Permanente** · enrollment: 20000 (estimated)

## Conditions studied

- Serious Mental Illness
- Type 2 Diabetes

## Interventions

- **BEHAVIORAL:** MetSense Risk Flag
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07264062
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07264062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07264062, "MetSense Pilot and Feasibility". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07264062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*